Sjællands Universitetshospital

Medicin og biovidenskab

1. Denmark 100%
2. Hidradenitis Suppurativa 89%
3. Cohort Studies 62%
4. Randomized Controlled Trials 53%
5. Neoplasms 51%
6. Systematic Reviews 49%
7. Therapeutics 45%
8. Population 40%
9. Mortality 39%
10. Registries 36%
11. Confidence Intervals 33%
12. Quality of Life 33%
13. Meta-Analysis 28%
14. Skin 28%
15. Colorectal Neoplasms 28%
16. Optical Coherence Tomography 27%
17. Survival 26%
18. Blood Donors 26%
19. Macular Degeneration 23%
20. Pain 23%
21. Breast Neoplasms 22%
22. Incidence 21%
23. Placebos 21%
24. Recurrence 21%
25. Polycythemia Vera 21%
26. Primary Myelofibrosis 21%
27. ST Elevation Myocardial Infarction 20%
28. Databases 19%
29. Pregnancy 18%
30. Biomarkers 17%
31. Cross-Sectional Studies 17%
32. Emergencies 17%
33. Child 17%
34. Prospective Studies 17%
35. Infections 16%
36. Guidelines 16%
37. Colonic Neoplasms 16%
38. Endocarditis 16%
39. Comorbidity 16%
40. Observational Studies 16%
41. Patient Reported Outcome Measures 15%
42. Odds Ratio 15%
43. Inflammation 15%
44. Exercise 15%
45. Electroencephalography 15%
46. Multicenter Studies 15%
47. Dermatology 14%
48. Coronavirus 14%
49. Percutaneous Coronary Intervention 14%
50. Essential Thrombocythemia 14%
51. Health 14%
52. HLA Antigens 14%
53. Psoriasis 14%
54. Genes 14%
55. Mutation 13%
56. Chronic Obstructive Pulmonary Disease 13%
57. Intensive Care Units 13%
58. Rheumatoid Arthritis 13%
59. Magnetic Resonance Imaging 13%
60. Myocardial Infarction 13%
61. Skin Diseases 13%
62. Skin Neoplasms 12%
63. Microscopic Colitis 12%
64. Delivery of Health Care 12%
65. Alzheimer Disease 12%
66. Radiotherapy 12%
67. Herniorrhaphy 11%
68. Stroke 11%
69. Actinic Keratosis 11%
70. Retrospective Studies 11%
71. Kidney 11%
72. Depression 11%
73. Nerve Block 11%
74. Interferons 11%
75. Biopsy 10%
76. Dialysis 10%
77. Neoplasm Metastasis 10%
78. Arthroplasty 10%
79. Hip 10%
80. Irritable Bowel Syndrome 10%
81. Colorectal Surgery 10%
82. Heart Failure 10%
83. Anti-Bacterial Agents 9%
84. Nurses 9%
85. Morbidity 9%
86. Inflammatory Bowel Diseases 9%
87. Clinical Trials 9%
88. Safety 9%
89. HLA-G Antigens 9%
90. Basal Cell Carcinoma 9%
91. Postoperative Pain 9%
92. Smoking 9%
93. Adalimumab 9%
94. Anxiety 9%
95. Atrial Fibrillation 9%
96. Wounds and Injuries 8%
97. Rectal Neoplasms 8%
98. Laparoscopy 8%
99. Opioid Analgesics 8%
100. Lung 8%